UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Tamoxifen: a most unlikely pioneering medicine

Nature reviews. Drug discovery, 2003-03, Vol.2 (3), p.205-213

Jordan, V. Craig

2003

Volltextzugriff (PDF)

MCF-7 : The first hormone-responsive breast cancer cell line

Cancer research (Chicago, Ill.), 1997-08, Vol.57 (15), p.3071-3078

1997

Volltextzugriff (PDF)

Antiestrogens and Selective Estrogen Receptor Modulators as Multifunctional Medicines. 1. Receptor Interactions

Journal of medicinal chemistry, 2003-03, Vol.46 (6), p.883-908

Jordan, V. Craig

2003

Volltextzugriff (PDF)

Tamoxifen (ICI46,474) as a targeted therapy to treat and prevent breast cancer

British journal of pharmacology, 2006-01, Vol.147 (S1), p.S269-S276

Jordan, V Craig

2006

Volltextzugriff (PDF)

Selective estrogen receptor modulation: Concept and consequences in cancer

Cancer Cell, 2004-03, Vol.5 (3), p.207-213

Jordan, V.Craig

2004

Volltextzugriff (PDF)

Antiestrogens and Selective Estrogen Receptor Modulators as Multifunctional Medicines. 2. Clinical Considerations and New Agents

Journal of medicinal chemistry, 2003-03, Vol.46 (7), p.1081-1111

Jordan, V. Craig

2003

Volltextzugriff (PDF)

Effects of Tamoxifen on Bone Mineral Density in Postmenopausal Women with Breast Cancer

The New England journal of medicine, 1992-03, Vol.326 (13), p.852-856

1992

Volltextzugriff (PDF)

Molecular mechanism of action of bisphenol and bisphenol A mediated by oestrogen receptor alpha in growth and apoptosis of breast cancer cells

British journal of pharmacology, 2013-05, Vol.169 (1), p.167-178

2013

Volltextzugriff (PDF)

The estrogen receptor: A model for molecular medicine

Clinical cancer research, 2003-06, Vol.9 (6), p.1980-1989

2003

Volltextzugriff (PDF)

Selective estrogen receptor modulators (SERMs): Mechanisms of anticarcinogenesis and drug resistance

Mutation research, 2005-12, Vol.591 (1), p.247-263

2005

Volltextzugriff (PDF)

Progesterone from ovulatory menstrual cycles is an important cause of breast cancer

Breast cancer research : BCR, 2023-05, Vol.25 (1), p.60-60

2023

Volltextzugriff (PDF)

International Union of Pharmacology. LXIV. Estrogen receptors

Pharmacological reviews, 2006-12, Vol.58 (4), p.773-781

2006

Volltextzugriff (PDF)

The biological role of estrogen receptors α and β in cancer

Critical reviews in oncology/hematology, 2004-04, Vol.50 (1), p.3-22

2004

Volltextzugriff (PDF)

Basic guide to the mechanisms of antiestrogen action

Pharmacological reviews, 1998-06, Vol.50 (2), p.151

1998

Volltextzugriff (PDF)

Intrinsic Mechanism of Estradiol-Induced Apoptosis in Breast Cancer Cells Resistant to Estrogen Deprivation

JNCI : Journal of the National Cancer Institute, 2005-12, Vol.97 (23), p.1746-1759

2005

Volltextzugriff (PDF)

High-Dose Oral Tamoxifen, a Potential Multidrug-Resistance-Reversal Agent: Phase I Trial in Combination With Vinblastine

JNCI : Journal of the National Cancer Institute, 1992-12, Vol.84 (23), p.1811-1816

1992

Volltextzugriff (PDF)

Estrogen-related receptors as emerging targets in cancer and metabolic disorders

Current topics in medicinal chemistry, 2006-01, Vol.6 (3), p.203-215

2006

Volltextzugriff (PDF)

Selective estrogen receptor modulation : A personal perspective

Cancer research (Chicago, Ill.), 2001-08, Vol.61 (15), p.5683-5687

JORDAN, V. Craig

2001

Volltextzugriff (PDF)

Tamoxifen, raloxifene, and the prevention of breast cancer

Endocrine reviews, 1999-06, Vol.20 (3), p.253-278

1999

Volltextzugriff (PDF)

Estrogenic potential of progestins in oral contraceptives to stimulate human breast cancer cell proliferation

Cancer research (Chicago, Ill.), 1992-12, Vol.52 (23), p.6539-6546

1992

Volltextzugriff (PDF)

The pharmacology and clinical uses of tamoxifen

Pharmacology & therapeutics (Oxford), 1984, Vol.25 (2), p.127-205

1984

Volltextzugriff (PDF)

The Small Heat Shock Protein αB-crystallin Is a Novel Inhibitor of TRAIL-induced Apoptosis That Suppresses the Activation of Caspase-3

The Journal of biological chemistry, 2005-03, Vol.280 (12), p.11059-11066

2005

Volltextzugriff (PDF)

A phase I study of high-dose tamoxifen for the treatment of refractory malignant gliomas of childhood

Clinical cancer research, 1997-07, Vol.3 (7), p.1109-1115

1997

Volltextzugriff (PDF)

3-methylcholanthrene and other aryl hydrocarbon receptor agonists directly activate estrogen receptor α

Cancer research (Chicago, Ill.), 2006-02, Vol.66 (4), p.2459-2467

2006

Volltextzugriff (PDF)

Abstract P3-05-11: The evolution of the estrogen receptor (ER) complex conformation governs estrogen-induced apoptosis in antihormone-resistant breast cancer cells

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.P3-P3-05-11

2016

Volltextzugriff (PDF)

1 – 25 von 338

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(316)
Mit Volltextzugriff
(289)

Publikationsform

Sprache

Englisch
(338)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Tamoxifen: a most unlikely pioneering medicine

MCF-7 : The first hormone-responsive breast cancer cell line

Antiestrogens and Selective Estrogen Receptor Modulators as Multifunctional Medicines. 1. Receptor Interactions

Tamoxifen (ICI46,474) as a targeted therapy to treat and prevent breast cancer

Selective estrogen receptor modulation: Concept and consequences in cancer

Antiestrogens and Selective Estrogen Receptor Modulators as Multifunctional Medicines. 2. Clinical Considerations and New Agents

Effects of Tamoxifen on Bone Mineral Density in Postmenopausal Women with Breast Cancer

Molecular mechanism of action of bisphenol and bisphenol A mediated by oestrogen receptor alpha in growth and apoptosis of breast cancer cells

The estrogen receptor: A model for molecular medicine

Selective estrogen receptor modulators (SERMs): Mechanisms of anticarcinogenesis and drug resistance

Progesterone from ovulatory menstrual cycles is an important cause of breast cancer

International Union of Pharmacology. LXIV. Estrogen receptors

The biological role of estrogen receptors α and β in cancer

Basic guide to the mechanisms of antiestrogen action

Intrinsic Mechanism of Estradiol-Induced Apoptosis in Breast Cancer Cells Resistant to Estrogen Deprivation

High-Dose Oral Tamoxifen, a Potential Multidrug-Resistance-Reversal Agent: Phase I Trial in Combination With Vinblastine

Estrogen-related receptors as emerging targets in cancer and metabolic disorders

Selective estrogen receptor modulation : A personal perspective

Tamoxifen, raloxifene, and the prevention of breast cancer

Estrogenic potential of progestins in oral contraceptives to stimulate human breast cancer cell proliferation

The pharmacology and clinical uses of tamoxifen

The Small Heat Shock Protein αB-crystallin Is a Novel Inhibitor of TRAIL-induced Apoptosis That Suppresses the Activation of Caspase-3

A phase I study of high-dose tamoxifen for the treatment of refractory malignant gliomas of childhood

3-methylcholanthrene and other aryl hydrocarbon receptor agonists directly activate estrogen receptor α

Abstract P3-05-11: The evolution of the estrogen receptor (ER) complex conformation governs estrogen-induced apoptosis in antihormone-resistant breast cancer cells

Suchergebnisse filtern